+ regulatory T (Treg) cells, which specifically express the transcription factor forkhead box p3, are potently immunosuppressive and characteristically possess a self-reactive T-cell receptor (TCR) repertoire. To determine the molecular basis of Treg suppressive activity and their self-skewed TCR repertoire formation, we attempted to reconstruct these Treg-specific properties in conventional T (Tconv) cells by genetic manipulation. We show that Tconv cells rendered IL-2 deficient and constitutively expressing transgenic cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) were potently suppressive in vitro when they were preactivated by antigenic stimulation. They also suppressed in vivo inflammatory bowel disease and systemic autoimmunity/ inflammation produced by Treg deficiency. In addition, in the thymus, transgenic CTLA-4 expression in developing Tconv cells skewed their TCR repertoire toward higher self-reactivity, whereas CTLA-4 deficiency specifically in developing thymic Treg cells cancelled their physiological TCR self-skewing. The extracellular portion of CTLA-4 was sufficient for the suppression and repertoire shifting. It interfered with CD28 signaling to responder Tconv cells via outcompeting CD28 for binding to CD80 and CD86, or modulating CD80/CD86 expression on antigen-presenting cells. Thus, a triad of IL-2 repression, CTLA-4 expression, and antigenic stimulation is a minimalistic requirement for conferring Treg-like suppressive activity on Tconv cells, in accordance with the function of forkhead box p3 to strongly repress IL-2 and maintain CTLA-4 expression in natural Treg cells. Moreover, CTLA-4 expression is a key element for the formation of a self-reactive TCR repertoire in natural Treg cells. These findings can be exploited to control immune responses by targeting IL-2 and CTLA-4 in Treg and Tconv cells.
Thymus-produced CD4
+ regulatory T (Treg) cells, which specifically express the transcription factor forkhead box p3, are potently immunosuppressive and characteristically possess a self-reactive T-cell receptor (TCR) repertoire. To determine the molecular basis of Treg suppressive activity and their self-skewed TCR repertoire formation, we attempted to reconstruct these Treg-specific properties in conventional T (Tconv) cells by genetic manipulation. We show that Tconv cells rendered IL-2 deficient and constitutively expressing transgenic cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) were potently suppressive in vitro when they were preactivated by antigenic stimulation. They also suppressed in vivo inflammatory bowel disease and systemic autoimmunity/ inflammation produced by Treg deficiency. In addition, in the thymus, transgenic CTLA-4 expression in developing Tconv cells skewed their TCR repertoire toward higher self-reactivity, whereas CTLA-4 deficiency specifically in developing thymic Treg cells cancelled their physiological TCR self-skewing. The extracellular portion of CTLA-4 was sufficient for the suppression and repertoire shifting. It interfered with CD28 signaling to responder Tconv cells via outcompeting CD28 for binding to CD80 and CD86, or modulating CD80/CD86 expression on antigen-presenting cells. Thus, a triad of IL-2 repression, CTLA-4 expression, and antigenic stimulation is a minimalistic requirement for conferring Treg-like suppressive activity on Tconv cells, in accordance with the function of forkhead box p3 to strongly repress IL-2 and maintain CTLA-4 expression in natural Treg cells. Moreover, CTLA-4 expression is a key element for the formation of a self-reactive TCR repertoire in natural Treg cells. These findings can be exploited to control immune responses by targeting IL-2 and CTLA-4 in Treg and Tconv cells.
immune tolerance | CD25 | thymic selection N aturally arising CD25 + CD4 + regulatory T (Treg) cells, which specifically express the transcription factor Foxp3, physiologically engage in the maintenance of immunological self-tolerance and homeostasis (1-3). The majority of them are produced by the thymus as a functionally distinct T-cell subpopulation, with the T-cell receptor (TCR) repertoire considerably skewed toward recognizing self-antigens. However, the molecular basis of Treg suppression, thymic generation, and self-skewed TCR repertoire formation is not fully understood. Foxp3 has been proposed to control the expression of putative suppressive molecules in Treg cells because ectopic expression of Foxp3 in conventional T (Tconv) cells is able to convert them to Treg-like cells with suppressive function (4, 5). Furthermore, deficiency or mutations of the Foxp3 gene hampers the development and suppressive function of natural Treg cells. A variety of molecules encoded by Foxp3-controlled genes are known to be involved in Treg cell function, although it is obscure how and to what extent each molecule contributes to Treg cell development and function (1-3, 6). One way to elucidate the key molecular mechanisms of Treg suppressive function and development would be to determine which Foxp3-controlled gene(s), when it is expressed in Tconv cells, can confer on them Treg-like in vivo and in vitro suppressive activity and/or developmental characteristics that include the acquisition of the self-reactive TCR repertoire.
IL-2 and CTLA-4, which are the molecules most stably repressed and activated, respectively, by Foxp3 in natural Treg cells, play key roles in Treg cell function and development (7, 8) . In vitro, exogenous IL-2 abrogates Treg suppressive activity, indicating its involvement in Treg-mediated suppression and suggesting that Treg cells may deprive responder T cells of IL-2 via their constitutively expressed high-affinity IL-2 receptor (9-11). Treg-specific CTLA-4 deficiency produces fatal autoimmune/ inflammatory disease via impairment of Treg suppressive activity (12). As possible roles of CTLA-4 in Treg-mediated suppression, several studies have shown that CTLA-4, which has much higher affinity than CD28 for their common ligands CD80 and CD86, outcompetes CD28 for binding to the ligands in the immunological synapse and also down-modulates CD80/CD86 expression on antigen-presenting cells (APCs), thereby depriving the CD28 signal from responder T cells (12-17). However, it has been shown repeatedly that Foxp3 + Treg cells from IL-2 receptoror CTLA-4-deficient mice with systemic inflammation still exhibit substantial in vitro suppressive function (12, 18, 19) . These findings, taken together, indicate that either an IL-2/IL-2 receptor-or CTLA-4-dependent suppressive mechanism alone is insufficient to produce full suppressive activity in Foxp3 + Treg cells. Foxp3 + Treg cell development in the thymus requires both IL-2 and CD28 signals, although either IL-2 or CD28 deficiency alone resulted in only a partial reduction of the number of Treg Significance Naturally occurring regulatory T (Treg) cells suppress aberrant or excessive immune responses, thereby maintaining immune self-tolerance and homeostasis. This study shows that a combination of IL-2 repression, CTLA-4 expression, and antigenic stimulation is able to convert conventional T cells to potently immunosuppressive Treg-like cells, which are able to deprive IL-2 and CD28 signal from other T cells. Like natural Treg cells, they acquire a self-skewed T-cell receptor repertoire in the course of their thymic development, enabling them to control autoimmune responses effectively. This Treg construction by targeting IL-2 and CTLA-4 in conventional T cells is a novel way of immune suppression.
cells (20, 21) . TCR signal intensity also plays a key role in Treg cell development. It has been suggested that developing CD4 + T cells expressing TCRs highly reactive with self-peptide/MHC ligands may preferentially differentiate into Foxp3 + Treg cells, resulting in their self-skewed TCR repertoire (22) (23) (24) (25) (26) (27) (28) . It remains to be determined, however, whether TCR signal intensity alone directly determines the fate of Treg cells and their self-skewed TCR repertoire in the course of thymic selection.
To address the above outstanding issues on Treg function and development, we have attempted to determine whether Treg-like suppressive activity and self-skewed TCR repertoire can be reconstructed in Tconv cells by modulating the expression of genes that are controlled by Foxp3 in natural Treg cells. We show that a combination of IL-2 nonproduction, high CTLA-4 expression, and antigenic stimulation is sufficient to convert naïve T cells to Treg-like cells with potent in vivo and in vitro suppressive activity. Furthermore, forced expression of CTLA-4 in developing T cells is able to produce self-skewed TCR repertoire in the thymus, whereas Treg-specific CTLA-4 deficiency cancels physiological acquisition of self-reactive TCR repertoire by developing Foxp3 + Treg cells. A CTLA-4 mutant form lacking the cytoplasmic signaling portion is sufficient for the suppression and repertoire skewing. These results provide key insights into the molecular mechanisms of Treg cell development and function and also delineate a minimum molecular requirement for constructing antigen-specific Treg-like suppressive T cells from Tconv cells without Foxp3. − [CD4 single-positive (SP)] cells significantly decreased in the thymus and the periphery of C4Tg, TLC4Tg, or CD28KO mice, without significant differences in the ratio and the number of CD4SP cells ( Fig. 1 A-D) (21, (29) (30) (31) . When accompanied by IL-2 deficiency, the frequency of Foxp3 + cells in these mice was further reduced, especially in the periphery, to less than 0.5% of CD4 + T cells compared with ∼8% in WT mice ( Fig. 1 B and D) .
In contrast with IL2KO mice, which spontaneously developed lymphoproliferation and died within a month after birth, IL2KO-C4Tg or IL2KO-TLC4Tg mice failed to develop splenomegaly and lymphoadenopathy at least by 4 wk after birth, surviving much longer than IL2KO mice, despite severe deficiency of Foxp3 + Treg cells (Fig. 1 E-G) (32) . In accord with these observations, actively proliferating (i.e., Ki-67 + ) peripheral CD4 + T cells, which were high in IL2KO mice, were substantially reduced in IL2KO-C4Tg or IL2KO-TLC4Tg mice to the levels comparable in WT, C4Tg, TLC4Tg, CD28KO, or IL2KO-CD28KO mice (Fig. 1B) Fig. 2A) , without suffering from splenomegaly at least by 4 wk after birth (Fig. 2B ). It contrasted with short life expectancy (less than 4 wk) of WT, C4Tg, or IL2KO BALB/c Scurfy mice, as previously shown with IL2KO C57BL/6 Scurfy mice (34) . The fractions of CD4 + T cells activated and/or proliferating (i.e., CD25 + , CD69 + , or Ki-67 + ) or producing cytokines such as IFN-γ, IL-4, and IL-10 were significantly lower in IL2KO-C4Tg Scurfy mice compared with WT Scurfy mice; T-cell activation and cytokine production were only partially suppressed in C4Tg Scurfy mice (Fig. 2 C-F) . Thus, the combination of IL-2 nonproduction and transgenic CTLA-4 expression, but not either one alone, was able to inhibit the development of systemic autoimmunity/inflammation normally consequent to Foxp3 + Treg cell deficiency.
In Vitro Hyporesponsiveness and Suppressive Activity of IL2KO-C4Tg + Tn cells. Addition of anti-CD28 or exogenous IL-2 effectively reversed the hypoproliferation of IL2KO, C4Tg, TLC4Tg, and IL2KO-C4Tg Tn cells, and also WT Treg cells; further, addition of both anti-CD28 and IL-2 abrogated the hypoproliferation of IL2KO-C4Tg CD4 + Tn cells and WT Treg cells in an additive manner. CTLA-4 expression alone down-regulated IL-2 production substantially but not completely, as indicated by the low IL-2 concentration in the supernatant of C4Tg Tn cell culture (Fig. 3B) ; nevertheless, this small amount of IL-2 rendered them more proliferative than IL2KO-C4Tg Tn cells (Fig. 3A) . In addition, TCR stimulation of IL2KO T cells in the presence of anti-CD28, and CD28KO T cells in the presence of IL-2, exhibited substantial proliferative responses, indicating that IL-2 and CD28 signals were complementary for T-cell proliferation to a certain extent. Collectively, these results indicate that deprivation of both IL-2 and CD28 signals is essentially required to inhibit the activation/proliferation of Tconv cells effectively. Also, similar hyporesponsiveness of C4Tg or TLC4Tg T cells, together with restoration of their responsiveness by CD28 stimulation, supports the notion that full-length or tailless CTLA-4 blocks CD28 signal to the T cells.
We next assessed possible in vitro suppressive activity of IL2KO-C4Tg T cells when they were either freshly prepared or preactivated in vitro for 2 d by anti-CD3, anti-CD28, and IL-2. Activation resulted in up-regulation of CD25, but failed to induce Foxp3 expression ( − CD4 + peripheral blood T cells are made IL-2 deficient and CTLA-4-expressing by retroviral gene transduction, they also exhibited similar in vitro suppressive activity comparable with that of human natural Foxp3 + Treg cells (Fig. S3) .
Thus, the combination of IL-2 nonproduction and constitutive CTLA-4 expression in conjunction with TCR/CD28-stimulated preactivation is able to confer Treg-like in vitro suppressive activity on Tconv cells, irrespective of their ability to produce inflammatory cytokines.
Mechanisms of In Vitro Suppression by IL2KO-C4Tg CD4
+ T Cells. The expression levels of Treg signature genes (e.g., Cd25, Itgb8, Socs2, and Eos) and the genes related to Treg suppressive function [e.g., Il10, Tgfb1, Il35(Il12a/Ebi3), Cd39/Cd73, Lag3, Granzyme B, and Galectin 1] were similar between IL2KO-C4Tg CD4 + T cells and WT CD4 + T cells and much lower than + Tn cells, whether they were IL2KO or not, down-modulated the expression of CD80 and CD86, but not CD40 or MHC class II, on live DCs (Fig. 5C ). TLC4Tg Tn cells, which expressed CTLA-4 at a higher level than C4Tg T cells in part due to the lack of endocytosis of cell surface CTLA-4 (29), similarly down-modulated CD80 and CD86 on DCs.
In addition, we assessed the capacity of IL2KO-C4Tg Tn cells and natural Treg cells to absorb IL-2 (Fig. 5D ). By incubating with a fixed amount of IL-2 for 20 h in the presence of anti-CD3 stimulation, preactivated IL2KO or IL2KO-C4Tg CD4 + T cells and natural Treg cells, all of which highly expressed CD25 (Fig.  4A) , absorbed small but significant amounts of mouse IL-2 (Fig.  5D ), whereas WT non-Treg cells secreted a large amount of the cytokine (Figs. 3B and 5D ). Similar incubation of the T cells with human IL-2 to exclude possible contribution of murine IL-2 produced by the incubated cells to measured IL-2 concentration revealed that Treg cells and activated IL2KO-C4Tg or WT T cells absorbed IL-2 to a comparable extent (Fig. 5E ). Importantly, WT CD25 + CD4
+ Treg cells and preactivated CD4 + T cells from IL2KO-C4Tg or TLC4Tg mice potently suppressed the proliferation of cocultured responder naïve CD4 + T cells; the suppression was abrogated by addition of agonistic anti-CD28 or exogenous IL-2 (Fig. 5F ).
Taken together, activated IL2KO-C4Tg CD4 + T cells dominantly aggregate around APCs, deterring responder T cells from contacting the APCs, and limit the availability of CD28 ligand and IL-2 to the former in a similar manner as natural Treg cells. evident colitis (35) . Interestingly, transfer of CD45RB high CD4 + Tn cells from IL2KO, C4Tg, or IL2KO-C4Tg mice failed to elicit body weight loss or diarrhea, despite the presence of systemic autoimmunity/inflammation in donor IL2KO mice (Fig. 6A) . Histology of colitis in these recipients was significantly less severe than the disease induced by WT CD45RB high CD4 + Tn cell transfer (Fig. 6B) . The majority of the transferred IL2KO or IL2KO-C4Tg CD4 + Tn cells were Foxp3 − even after 2 mo; Ki-67 expression was equivalent between IL2KO-C4Tg T cells and WT T cells in the recipients (Fig. 6C ). In contrast with less expansion of C4Tg or IL2KO-C4Tg T cells compared with WT T cells, IL2KO T cells expanded more with higher Ki-67 expression than WT T cells; however, they failed to induce colitis ( Fig. 6 C and D) . (Fig. 6 E-G) . They exhibited less expansion than cotransferred WT T cells (Fig. 6 H and I) , contrasting with cotransfer of Foxp3 + Treg cells, which proliferated more extensively than Foxp3
− T cells during the first week after transfer (Fig. S4) . In contrast, the development of IBD was markedly suppressed both clinically and histologically when IL2KO-C4Tg CD45RB high CD4 + Tn cells were inoculated 7 d before the transfer of WT CD45RB high CD4 + Tn cells (Fig. 6 E-G) ; 2 mo after the transfer, both the transferred populations had expanded to an equivalent level in the recipients (Fig. 6 H and I) . Similarly, 7-d prior transfer of IL2KO or C4Tg CD4 + T cells effectively suppressed colitis development (Fig. S5 A and B) . In addition, in vitro-activated ovalbumin (OVA)-specific TCR transgenic IL2KO CD4 + Tn cells suppressed OVA-specific Tn cells to mediate delayed type hypersensitivity reaction against OVA, as did OVA-specific natural Treg cells (Fig. S5C) . Thus, IL2KO-C4Tg Tn cells are able to suppress the development of IBD dominantly when they become activated and expand to a certain extent before the activation of effector Tn cells. (Fig. 1 C and D) . However, transgenic CTLA-4 expression significantly increased the proportion of Foxp3 − CD4SP thymocytes expressing deletional TCR Vβ subfamilies (e.g., Vβ3, 5, 11, or 12) reactive with endogenous superantigens, with no increase in nondeletional Vβ subfamilies (e.g., Vβ2, 6, 8, or 14) on the BALB/c background (Fig. 7A) ( Fig. 7 A and B) . Analysis of TCR transgenic mice for the repertoire of T cells expressing endogenous TCR α-chains together with the transgenic β-chain (i.e., frequency of Jα segment used by T cells expressing a particular endogenous Vα) revealed that the TCR repertoire of WT CD25 + CD4SP Treg thymocytes was closer to IL2KO-C4Tg CD25 − CD4SP thymocytes than to WT CD25 − CD4SP thymocytes (Fig. S6 ). This self-skewing of the TCR repertoire in Foxp3 − CD4SP thymocytes also occurred in TLC4Tg mice, indicating that the CD80/CD86-binding extracellular portion of CTLA-4, without the intracellular signaling domain, was sufficient for the skewing (Fig. 7C) . Functionally, IL2KO-C4Tg CD25 − CD4SP thymocytes and WT CD25 + CD4SP Treg thymocytes showed higher proliferative activity to autologous splenic APCs than WT CD25 − CD4SP thymocytes in an in vitro autologous mixed lymphocyte reaction (AMLR) in the presence of IL-2 and agonistic anti-CD28 (Fig. 7D ). It contrasted with equivalent proliferative responses of these three populations to polyclonal stimulation with anti-CD3, anti-CD28, and IL-2 as shown in (Fig. 7 A, E, and F). Notably, this physiological self-skewing in the TCR Vβ repertoire of Foxp3 + CD4SP thymocytes was absent in Treg-specific CTLA-4-deficient BALB/c mice (Fig. 7F) . 
Discussion
In this study, we showed that Treg-like hyporesponsiveness and suppressive activity can be produced in Tconv cells simply by maintaining high expression of CTLA-4 and repressing IL-2 production. Once preactivated by antigenic stimulation, such IL-2 nonproducing and CTLA-4-expressing T cells exert potent in vivo and in vitro suppression in a similar manner to Foxp3 + natural Treg cells. Furthermore, a Treg-like self-skewed TCR repertoire can be bestowed on developing Tconv cells by CTLA-4 overexpression, whereas Treg-specific CTLA-4 deficiency cancels physiological acquisition of a self-reactive TCR repertoire by developing Foxp3 + Treg cells in the thymus. Together with the requirement of IL-2 for thymic Treg development, these findings illustrate essential roles of IL-2 and CTLA-4 for Treg function and development in the thymus and the periphery.
Depriving responder T cells of CD28 and/or IL-2 signal, especially both, is a potent mechanism of suppression. CTLA-4 expression is able to deprive CD28 signal from responder T cells as demonstrated by the acquisition of suppressive activity by CTLA-4-expressing Tconv cells and impaired Treg suppressive function in CTLA-4-deficient Treg cells (12, 37). CTLA-4, which is highly and constitutively expressed on C4Tg T cells and cell-intrinsic and -extrinsic functions of CTLA-4 in controlling immune responses. For example, CTLA-4 may increase T-cell motility and override the TCR-induced stop signal required for stable conjugate formation between T cells and APCs, although this CTLA-4 function did not affect motility of Treg cells (38, 39) . CTLA-4 ligation may induce the tryptophan catabolizing enzyme indoleamine 2,3-dioxygenase, which locally depletes tryptophan and produces immunosuppressive tryptophan catabolites, although inhibition of the enzyme failed to abrogate suppression by activated IL2KO-C4Tg CD4 + T cells in these experiments (40, 41) . Soluble CTLA-4 derived from activated C4Tg, TLC4Tg, or Foxp3 + Treg cells may block CD80/CD86 (42) . The precise contribution of each mechanism of CTLA-4-dependent APC modulation is not fully understood and is currently under investigation.
In addition to these CTLA-4-dependent suppressive mechanisms, activated IL2KO-C4Tg T cells and Foxp3 + Treg cells are likely to exhibit suppressive activity via reducing IL-2 concentration in the surroundings by a combination of IL-2 absorption, their nonproduction of IL-2, and suppressed production by responder T cells. Deprivation of IL-2, a cytokine crucial for T-cell activation, differentiation, and survival, appears to induce apoptosis in partially activated responder T cells (11, 43) . Although the exact extent of the contribution of IL-2 absorption to in vivo suppression remains to be determined, it is worth emphasizing that IL-2 nonproduction in itself by IL2KO-C4Tg T cells and natural Treg cells is a critical prerequisite for their in vivo suppressive function; if activated Treg cells could secrete IL-2, this would attenuate suppression.
Stimulation of IL2KO-C4Tg T cells via TCR is required for their effective exertion of suppression, as is the case with Foxp3 + natural Treg cells (9, 10). This TCR prestimulation of IL2KO-C4Tg T cells and Foxp3
+ natural Treg cells up-regulates their expression of adhesion molecules including LFA-1 and ICAM-1 (with a conformational change of LFA-1), which are critically required for outcompeting naïve T cells for interaction with APCs and also for augmenting the interaction of CTLA-4 with CD80/CD86 on APCs (14) . It also up-regulates the expression of the IL-2 receptor and may enhance their IL-2 absorption. Moreover, TCR stimulation by self-antigens or commensal microbial antigens induces in vivo expansion of antigen-specific IL2KO-C4Tg T cells and Foxp3 + Treg cells, leading to their local numerical dominance over antigenspecific effector T cells (44) . Thus, TCR stimulation is able to expand IL-2-hypoproducing and CTLA-4-expressing T cells and evoke their suppressive activity in vivo and in vitro.
These roles of IL-2, CTLA-4, and TCR stimulation for T cellmediated suppression support the notion that the IL-2-and CTLA-4-dependent suppressive mechanism, which is evoked by TCR stimulation, can be a core and ubiquitous mechanism of suppression mediated by natural Foxp3 + Treg cells. Some of the other functions of natural Foxp3 + Treg cells may augment the core suppressive mechanism (6). For example, IL-10 (and TGF-β), which is secreted by chronically stimulated Treg cells and other T cells, is able to down-modulate CD80/CD86 expression by
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Thy1.2 58.5 DCs and reduce IL-2 production by responder T cells, thus acting in synergy with the IL-2-and CTLA-4-dependent suppressive mechanism (45, 46) . In addition, expression of specific transcriptional factors of Th1, Th2, Tfh, and Th17 cells may be required for Treg cells to effectively suppress each type of inflammation (e.g., via controlling their migration to inflammation sites) (3, 47-51). It is under investigation whether installment of additional Treg cell properties, including the expression of Th type-specific transcriptional factors, would enable IL2KO-C4Tg T cells to control specific inflammatory responses more efficiently. CTLA-4 is also a key molecule for forming a self-skewed TCR repertoire in developing T cells, as indicated by the following findings. Forced expression of full length or tailless CTLA-4 and resulting reduction of CD28 signaling skewed the TCR repertoire of developing Foxp3 − Tconv cells toward higher selfreactivity without significantly affecting their cell number (29, 52, 53) . In line with this finding, the TCR repertoire of CD28-deficient Tconv cells was reported to be slightly more selfreactive than WT Tconv cells (29, 52, 53) . On the other hand, Treg-specific CTLA-4 deficiency cancelled physiological selfskewing of their TCR repertoire. In addition, CTLA-4-deficient TCR transgenic mice bore an altered TCR repertoire in both Treg and Tconv cells (54) . These findings when taken together indicate that a common CTLA-4-dependent mechanism of TCR self-skewing operates in developing Foxp3
− Tconv cells overexpressing CTLA-4, as well as Foxp3 + natural Treg cells, which physiologically express the molecule in the course of their thymic development from the Foxp3 −
CD25
+ Treg precursor stage to the Foxp3 + stage. That is, given that CD28 signaling physiologically amplifies TCR signal (55), attenuation of TCR signal due to the CTLA-4-dependent CD28 signal reduction allows some of those normally deleted highly self-reactive T cells to escape negative selection while inhibiting positive selection of some non-or low self-reactive T cells; these events together shift the whole TCR repertoire toward higher self-reactivity (Fig. S7) . It is also of note that, without CD28-dependent amplification of the TCR signal in CD28-deficient mice and C4Tg or TLC4Tg mice, developing T cells fail to generate a TCR signal sufficiently potent to induce Foxp3 expression, resulting in specific reduction of Foxp3 + Treg cells in these mice (Fig. 1) . In contrast, in Tregspecific CTLA-4-deficient mice, a TCR signal amplified by a CD28 signal (without CTLA-4-dependent signal reduction) is sufficiently potent to induce Foxp3 expression in some T cells, leading to the development of Foxp3 + cells without self-skewing in their TCR repertoire. This model of CTLA-4-dependent Treg development and self-skewing of their TCR repertoire explains how Treg and Tconv cells acquire respective TCR repertoires that are apparently distinct but overlapping to a certain extent (22) . It remains to be determined how Foxp3-dependent and -independent mechanisms control CTLA-4 expression and IL-2 nonproduction, which also appears to contribute somehow to Treg TCR repertoire skewing (56) .
We have thus shown that self-reactive Treg-like suppressive T cells can be constructed from naïve T cells simply by targeting IL-2 and CTLA-4, without Foxp3. This minimalistic construct of Treg-like cells implies that their suppressive properties could be shared by other reported Foxp3 − suppressive T cells, which generally appear to be IL-2 hypoproducing and readily express CTLA-4 on antigenic stimulation, and are suppressive in shortterm in vitro suppression assays (46, (57) (58) (59) (60) (61) (62) (63) (64) and in an experimental IBD model (65) . Furthermore, any antigen-stimulated non-Treg cells are potentially able to temporarily exhibit suppressive activity on naïve T cells in a negative feedback manner when they cease to produce IL-2 and still retain CTLA-4 expression (or when CTLA-4 expression inhibits IL-2 production) in the course of immune responses (Fig. S2) Cell Preparation. Cell suspensions from lymph nodes and thymus were stained with specific antibodies and sorted with MoFlo (Beckman Coulter) with a typical purity of more than 97%. Cells were cultured in RPMI 1640 medium with 10% (vol/vol) FCS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 50 μM 2-mercaptoethanol. To analyze absorption of human IL-2, 250 pg/mL of recombinant human IL-2 was added instead of mouse IL-2. Mouse IL-2 and IFN-γ concentration in the culture supernatant was determined using the mouse IL-2 and IFN-γ detection kit (eBioscience), respectively. Human IL-2 concentration was determined using the human IL-2 detection kit (BD Biosciences).
Quantitative PCR Analysis. RNA was extracted from cell lysates with RNAeasy (QIAGEN), and cDNAs were prepared with random primers and reverse transcriptase III (Invitrogen). The amount of each cDNA was determined with LightCycler 480 (Roche) with the specific primers listed in Table S1 . The quantity of RNA was normalized with the amounts of mRNA of Cd4. Body weight and signs of IBD were monitored twice a week for 2 mo. Signs of IBD include diarrhea, reduction in body weight to less than 90% of initial weight, or death. After 2 mo, mice were killed, and colons were fixed in 10% formalin. Lymphocytes in mesenteric lymph nodes were counted, stained with antibodies for Thy1.1, Thy1.2, CD4, Foxp3, and Ki-67, and analyzed with FACS Calibur. Colon sections were stained with H&E, and histological severity of colitis was scored (0 = intact colon indistinguishable from control BALB/c mice, 1 = mild colitis with limited cellular infiltration and slight epithelial cell hyperplasia, 2 = moderate colitis with cellular infiltration and mild distraction of mucosa, 3 = severe colitis with extensive cellular infiltration and marked distraction of mucosa).
TCR Repertoire Analysis. Thymocytes were stained with anti-CD4, anti-CD8, anti-Foxp3, and antibodies specific for TCRVβ2, Vβ3, Vβ5, Vβ6, Vβ8.1/8.2, Vβ8.3, Vβ11, Vβ12, and Vβ14, and proportions of CD4SP thymocytes expressing each TCRVβ subfamily among Foxp3 − and Foxp3 + CD4SP thymocytes were determined with FACS Canto II (BD Biosciences). For sequencing of TCRJα, CDR3 regions with TCRVα10 were amplified from CD4SP thymocytes expressing DO11.10 transgenic TCR Vβ. See also SI Materials and Methods.
Statistical Method. One-way ANOVA followed by Tukey-Kramer's test was used to analyze the difference among more than two groups in Figs. 1D, 3A, 4 C and E, and 6 F and I. A paired t test was applied in Fig. 7 C and F. Log-rank
